Navigation Links
Breast Cancer in Men Lead to Second Primary Cancers

Men treated for breast cancer face a significantly high risk of getting cancer once again according to a recent study.//

More than 10 percent of these men ultimately developed second primary cancers, particularly those of the breast, stomach and skin. Hence the researchers recommend that a close monitoring is necessary for spotting any possible second onset of cancer in them.

Hoda Anton-Culver, Sacha Satram-Hoang and Argyrios Ziogas from UCI's Genetic Epidemiology Research Institute accessed California Cancer Registry data from 1988 to 2003 and found that 1,926 men aged 85 or younger had been diagnosed with a first primary breast cancer.

Of these, 221 (11.5 percent) went on to develop a second primary cancer at least two months after the breast cancer diagnosis. The researchers conclude that men diagnosed with a first primary breast cancer have a 16 percent increased risk in developing a second cancer as compared to the risk for men in the general population in getting a first cancer. And in further comparisons to the general population of men, the researchers observed higher rates of breast, colorectal, bladder and stomach cancers and of melanoma in men who have had breast cancer.

"Even more disturbing, we found that men with breast cancer are diagnosed with later-stage disease and that patients with onset of the disease at a young age are even more likely to develop a second cancer," said Anton-Culver, who is chief of epidemiology in the UCI School of Medicine. "These findings indicate that male breast cancer patients need to be primary candidates for active cancer screening, early detection and cancer prevention counseling."

Male breast cancer is a rare disease, each year afflicting about 1,700 men in the United States. Risk factors include increasing age, radiation, high estrogen levels caused by obesity, chronic liver conditions such as cirrhosis, and genetic conditions or family history.

Source-Eurekale rt
PRI
'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency based in ... Palo Alto, is proud to announce an important upgrade to its geographic information pages, ... care close to home, and by having city-specific pages, NuevaCare is answering that information ...
(Date:2/26/2017)... PA (PRWEB) , ... February 26, 2017 , ... ... and services with Pay-For-Performance B2B Marketing. B2B Sellers will now only pay for B.A.N.T. ... Robert Hennessey, the founder of IndustryArchive.Org, said, “Given the new reality that B2B buyers ...
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the 10th ... Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on how ... management. , ODH will also have an exhibit booth where attendees may speak to ...
(Date:2/26/2017)... ... 26, 2017 , ... Occupational pesticide exposure is linked to ... mutation, according to a study released today at the 1st Pan American Parkinson’s ... between pesticides and incidence of sporadic PD through occupational exposure. This latest study, ...
(Date:2/24/2017)... Lake MN (PRWEB) , ... February 24, 2017 ... ... launch of its newly designed TaskMate Go. Core benefits and advantages built into ... finish and a stylish, functional look and feel. Ability to gain the benefits ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... on tissue protection, repair and regeneration, today announced ... received a positive response from the U.S. FDA ... RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 is ... beta 4 ("Tß4") as the active pharmaceutical ingredient. ...
(Date:2/27/2017)...  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) ... Ph.D., as President and Chief Executive Officer (CEO) and member ... Craig succeeds Richard Love , interim President and CEO ... Directors.  Dr. Craig has over 20 years of experience in ... Europe . "On behalf of ...
(Date:2/24/2017)... Following receiving CE Marking in Europe ... AMAR is a major milestone for the country where the device was developed ... market in Israel   ... inclusion in the National Health Basket , Israel , ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of advanced wound ...
Breaking Medicine Technology: